IPO Date: Nov 21 to Nov 25 2025
Listing Date: Nov 28 2025
(i)Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I; and(ii)General corporate purposes.
-
-
-
-
-
-
-
MUFG Intime India Pvt Ltd.
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sudeep Pharma has informed that the officials of the Company will be meeting Investors/Analysts (Participants) on 23rd March 2026 at 12:00 pm onwards in Mumbai (1x1 / Group). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
Pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), V2 Retail has informed that a meeting of the Board of Directors of the company is scheduled to be held on Thursday, 28th May, 2026, to consider, approve and take on record the audited financial results of the Company for the fourth quarter/year ended March 31, 2026 and other business matters. Further, according to the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their immediate Relatives, the trading window for dealing in securities of the company shall remain closed with effect from Wednesday, April 01, 2026 till 48 hours after declaration of Audited Financial Results for the fourth quarter/year ended March 31, 2026. The notice of the said Board Meeting will also be uploaded on the Company’s website: www.v2retail.com.
Sansera Engineering has informed that it attached a copy of Earning Release on the audited financial results of the Company for the quarter and year ended March 31, 2026. The above announcements will also be made available on the website of our Company at www.sansera.in.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Sudeep Pharma Ltd. IPO is ₹594.81 - 626.50 crore.
The Sudeep Pharma Ltd. IPO opens for subscription on 2025-11-21 and closes on 2025-11-25.
The price range of Sudeep Pharma Ltd. IPO is ₹563.00 to ₹593.00.
The lot size of Sudeep Pharma Ltd. IPO is 25 shares.
The registrar of Sudeep Pharma Ltd. IPO is MUFG Intime India Pvt Ltd..
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.